Therapy News and Research

RSS

Delivering miRNAs to treat patients with inflammatory bowel disease

Inflammatory bowel disease, such as Crohn disease and ulcerative colitis, are chronic inflammatory diseases of unknown cause, and the number of IBD patients is on the rise.

28 Aug 2018

Non-invasive test could help avoid unnecessary heart procedures

Unnecessary heart procedures can be avoided with a non-invasive test, according to late breaking research presented at ESC Congress 2018 and published in Journal of the American College of Cardiology.

28 Aug 2018

Blood pressure lowering therapy and statins continue to improve survival in patients with hypertension

Blood pressure and cholesterol lowering drugs continue to improve survival in patients with hypertension after more than a decade, according to late breaking results from the ASCOT Legacy study presented at ESC Congress 2018 and published in The Lancet.

28 Aug 2018

Combined oral anticoagulant and antiplatelet therapy linked to poor prognosis in atrial fibrillation

Combined oral anticoagulant and antiplatelet therapy is associated with a worse prognosis than anticoagulation alone in newly diagnosed atrial fibrillation patients without a clear indication for antiplatelets, according to late breaking results from the GARFIELD-AF registry presented today at ESC Congress 2018.

28 Aug 2018

New smartphone app can help detect atrial fibrillation

A smartphone application can help in screening for atrial fibrillation, according to late breaking results from the DIGITAL-AF study presented at ESC Congress.

28 Aug 2018

Blood pressure medication slows enlargement of the aorta in patients with Marfan syndrome

Treatment with a drug to lower blood pressure slows enlargement (dilatation) of the aorta in children and young adults with Marfan syndrome, according to late breaking results from the AIMS trial presented today in a Hot Line Session at ESC Congress 2018.

28 Aug 2018

New findings reveal potential role of interleukin-1 alpha in risk for heart attacks, strokes

XBiotech Inc. announced today the publication of findings that point toward a white blood cell-derived interleukin-1 alpha (IL-1⍺) as a cause of blood clots that could lead to heart attacks or strokes.

28 Aug 2018

New safety guideline released for prescribing biological therapies in inflammatory arthritis

The British Society for Rheumatology publishes its latest clinical guideline in Rheumatology, the UK’s key specialist journal in the sector. The new guideline updates and presents two previous guidelines into one set of evidence based recommendations on the vital safety aspects of prescribing biological therapies in inflammatory arthritis.

28 Aug 2018

Biochemist's startup secures license for developing technology that could treat PTSD

A biochemist's startup company announced Monday that it had secured an exclusive patent license agreement with the Air Force Research Laboratory for a breakthrough technology that could help military veterans suffering from a post-traumatic stress disorder.

28 Aug 2018

TB Alliance initiates SimpliciTB to test if new four-drug regimen can treat most types of tuberculosis

TB Alliance has initiated a pivotal clinical trial, SimpliciTB, that will evaluate whether a new four-drug regimen can treat most types of tuberculosis including multidrug-resistant TB more quickly and effectively than currently-available treatments.

28 Aug 2018

New combination treatment could help some people with advanced melanoma

A UCLA-led study has found that a treatment that uses a bacteria-like agent in combination with an immunotherapy drug could help some people with advanced melanoma, an aggressive form of skin cancer, live longer.

28 Aug 2018

Scientists develop urine diagnostic to detect parasitic worms that cause river blindness

Scientists at Scripps Research have developed a urine diagnostic to detect the parasitic worms that cause river blindness, also called onchocerciasis, a tropical disease that afflicts 18 to 120 million people worldwide.

28 Aug 2018

Researchers launch clinical trial to assess new drug combination against metastatic breast cancers

Researchers at University of California San Diego School of Medicine have launched a phase Ib clinical trial to assess the safety and tolerability of cirmtuzumab, in combination with standard chemotherapy, to treat metastatic or locally advanced breast cancer that cannot be surgically removed.

28 Aug 2018

MUSC and Siemens Healthineers join hands to advance quality of health care in South Carolina

The Medical University of South Carolina and Siemens Healthineers have formed a first-of-its-kind strategic partnership with the mutual goal of advancing the quality of health care in South Carolina.

28 Aug 2018

Use of HIV RNA expression inhibitors restores immune function in HIV patients on cART

Immune activation and inflammation persist in the majority of treated HIV-infected individuals and is associated with excess risk of mortality and morbidity.

28 Aug 2018

UIC receives $7 million for developing programs to prevent adolescent depression

The University of Illinois at Chicago has been awarded $7 million in funding from the Patient-Centered Outcomes Research Institute to develop programs to prevent depression among teens.

27 Aug 2018

Amphetamine regimen does not improve post-stroke motor recovery

A pilot clinical trial exploring the benefit of d-amphetamine combined with physical therapy for stroke patients found no evidence that the regimen improved post-stroke motor recovery.

27 Aug 2018

Study shows new options to lower heart disease risk in people with diabetes

A drug used to manage diabetes may reduce heart disease and death in people with diabetes regardless of their cholesterol levels and whether they are on a statin therapy, suggests a new analysis of the LEADER trial.

27 Aug 2018

New personalized cellular therapy approved for use in the European Union

The European Commission has approved a personalized cellular therapy developed at the University of Pennsylvania's Abramson Cancer Center, making it the first chimeric antigen receptor (CAR) T cell therapy permitted for use in the European Union in two distinct indications.

27 Aug 2018

Antiplatelet monotherapy appears to be safer but does not reduce risk of heart attack

Long-term antiplatelet monotherapy after stenting is safe but does not reduce the risk of death or heart attack compared to standard dual antiplatelet therapy, according to late breaking results from the GLOBAL LEADERS trial presented today in a Hot Line Session at ESC Congress 2018 and published in The Lancet.

27 Aug 2018

Therapy News and Research

Delivering miRNAs to treat patients with inflammatory bowel disease

Non-invasive test could help avoid unnecessary heart procedures

Blood pressure lowering therapy and statins continue to improve survival in patients with hypertension

Combined oral anticoagulant and antiplatelet therapy linked to poor prognosis in atrial fibrillation

New smartphone app can help detect atrial fibrillation

Blood pressure medication slows enlargement of the aorta in patients with Marfan syndrome

New findings reveal potential role of interleukin-1 alpha in risk for heart attacks, strokes

New safety guideline released for prescribing biological therapies in inflammatory arthritis

Biochemist's startup secures license for developing technology that could treat PTSD

TB Alliance initiates SimpliciTB to test if new four-drug regimen can treat most types of tuberculosis

New combination treatment could help some people with advanced melanoma

Scientists develop urine diagnostic to detect parasitic worms that cause river blindness

Researchers launch clinical trial to assess new drug combination against metastatic breast cancers

MUSC and Siemens Healthineers join hands to advance quality of health care in South Carolina

Use of HIV RNA expression inhibitors restores immune function in HIV patients on cART

UIC receives $7 million for developing programs to prevent adolescent depression

Amphetamine regimen does not improve post-stroke motor recovery

Study shows new options to lower heart disease risk in people with diabetes

New personalized cellular therapy approved for use in the European Union

Antiplatelet monotherapy appears to be safer but does not reduce risk of heart attack

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News